Floatz logo

Topamax

Common Migraine

Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaPhase 4 / ApprovedDormant
BBB
78/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
95/ 100

Competitive context

20 Active assets in the Common Migraine cohort.

Asset / SponsorPhaseRating
Dihydroergotamine mesylate
Satsuma Pharmaceuticals, Inc.
Phase 3BBB
PROPRANOLOL
Norwegian University of Science and Technology
Phase 3BB
METOCLOPRAMIDE
Assistance Publique - Hôpitaux de Paris
Phase 4BB
Rimegepant
University of South Florida
Phase 4BB
DEXKETOPROFEN
Kecioren Education and Training Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Topamax is also rated in:

focal epilepsyDormant
A
Indicative ·
80 / 100
View asset →
migraine with auraDormant
BBB
Indicative ·
78 / 100
View asset →
headache disorderDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →